• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病性类脂质渐进性坏死:一例儿科病例报告。

Necrobiosis Lipoidica Diabeticorum: A pediatric case report.

作者信息

Bonura Clara, Frontino Giulio, Rigamonti Andrea, Battaglino Roseila, Favalli Valeria, Ferro Giusy, Rubino Chiara, Del Barba Paolo, Pesapane Filippo, Nazzaro Gianluca, Gianotti Raffaele, Bonfanti Riccardo, Meschi Franco, Chiumello Giuseppe

机构信息

Ospedale San Raffaele Scientific Institute; Department of Pediatrics; Milano, Italy.

Università degli Studi di Milano; Fondazione IRCCS Ca' Granda Osp. Maggiore Policlinico; Department of Pathophysiology and Transplantation; Milano, Italy.

出版信息

Dermatoendocrinol. 2014 Jan 1;6(1):e27790. doi: 10.4161/derm.27790. Epub 2014 Jan 17.

DOI:10.4161/derm.27790
PMID:24575162
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3917223/
Abstract

INTRODUCTION

Necrobiosis lipoidica (NL) is a rare chronic granulomatous dermatitis that usually appears in the lower extremities. It affects about 0.3-1.2% of diabetic patients, the majority of whom have type 1 diabetes. The etiology and pathogenesis of this disorder are still unclear. NL is characterized by skin rash that usually affects the shins. The average onset is 30 years, with females being affected more commonly. There are very few reported cases of necrobiosis lipoidica in children.

CASE REPORT

We report a case of a 16 year old girl affected by type 1 diabetes mellitus (15 years disease duration) who developed an erythematous nodular rash on the lower extremities and interscapular area. In the suspect of necrobiosis lipoidica, a skin biopsy was performed (lower extremities and interscapular area). The microscopic evaluation of the pretibial lesions was suggestive of necrobiosis lipoidica. The smaller lesions in the interscapular area showed signs of perivascular dermatitis which could be consistent with early stages of necrobiosis lipoidica. Local treatment with tacrolimus determined a progressive improvement of the lesions.

CONCLUSION

In patients with T1DM, diagnosis of NL of the lower legs is usually unequivocal. However, diagnosis may be more challenging in the presence of lesions with recent onset and/or atypical clinical presentation and unusual site. In these cases, NL must always be taken in consideration in order to avoid misdiagnosis, wrong/late treatment decisions and progression to ulceration.

摘要

引言

类脂质渐进性坏死(NL)是一种罕见的慢性肉芽肿性皮炎,通常出现在下肢。它影响约0.3%-1.2%的糖尿病患者,其中大多数为1型糖尿病患者。这种疾病的病因和发病机制仍不清楚。NL的特征是皮疹,通常累及小腿。平均发病年龄为30岁,女性更易受累。儿童类脂质渐进性坏死的报道病例非常少。

病例报告

我们报告一例16岁1型糖尿病女孩(病程15年),其下肢和肩胛间区域出现红斑结节性皮疹。怀疑为类脂质渐进性坏死时,进行了皮肤活检(下肢和肩胛间区域)。胫前病变的显微镜评估提示类脂质渐进性坏死。肩胛间区域较小的病变显示血管周围性皮炎迹象,这可能与类脂质渐进性坏死的早期阶段一致。他克莫司局部治疗使病变逐渐改善。

结论

在1型糖尿病患者中,小腿NL的诊断通常明确。然而,在存在近期发病的病变和/或非典型临床表现及不寻常部位时,诊断可能更具挑战性。在这些情况下,必须始终考虑NL,以避免误诊、错误/延迟的治疗决策以及进展为溃疡。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/65700fc5d9cd/de-6-e27790-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/78a451485b7a/de-6-e27790-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/2c66c4b60f34/de-6-e27790-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/65700fc5d9cd/de-6-e27790-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/78a451485b7a/de-6-e27790-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/2c66c4b60f34/de-6-e27790-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8424/3917223/65700fc5d9cd/de-6-e27790-g3.jpg

相似文献

1
Necrobiosis Lipoidica Diabeticorum: A pediatric case report.糖尿病性类脂质渐进性坏死:一例儿科病例报告。
Dermatoendocrinol. 2014 Jan 1;6(1):e27790. doi: 10.4161/derm.27790. Epub 2014 Jan 17.
2
Truncal necrobiosis lipoidica diabeticorum: A first case report.糖尿病性脂性渐进性坏死:首例病例报告。
Int J Surg Case Rep. 2020;77:311-313. doi: 10.1016/j.ijscr.2020.11.009. Epub 2020 Nov 8.
3
Atypical presentation of necrobiosis lipoidica in a pediatric patient.一名儿科患者的类脂质渐进性坏死的非典型表现。
Pediatr Dermatol. 2019 Jan;36(1):e31-e33. doi: 10.1111/pde.13716. Epub 2018 Dec 2.
4
Necrobiosis Lipoidica: Atypical Presentation in a Diabetic Girl.类脂质渐进性坏死:一名糖尿病女孩的非典型表现。
Case Rep Dermatol. 2021 Nov 30;13(3):547-552. doi: 10.1159/000520588. eCollection 2021 Sep-Dec.
5
Necrobiosis lipoidica diabeticorum: A case-based review of literature.糖尿病性类脂质渐进性坏死:基于病例的文献综述
Indian J Endocrinol Metab. 2012 Jul;16(4):614-20. doi: 10.4103/2230-8210.98023.
6
Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus.类脂质渐进性坏死:他克莫司早期诊断与治疗
Case Rep Dermatol. 2011 Apr 18;3(1):89-93. doi: 10.1159/000327936.
7
Necrobiosis lipoidica diabeticorum: a clinicopathologic study.糖尿病性类脂质渐进性坏死:一项临床病理研究。
J Am Acad Dermatol. 1988 Mar;18(3):530-7. doi: 10.1016/s0190-9622(88)70076-6.
8
Perforating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: a new case reported.1型糖尿病女童的穿通性类脂质渐进性坏死:1例新病例报告
Dermatol Online J. 2008 Jul 15;14(7):11.
9
Necrobiosis lipoidica in a Nigerian woman - Report of a case.一名尼日利亚女性的类脂质渐进性坏死——病例报告
Niger J Clin Pract. 2019 Nov;22(11):1626-1628. doi: 10.4103/njcp.njcp_40_19.
10
Update on necrobiosis lipoidica: a review of etiology, diagnosis, and treatment options.关于脂性渐进性坏死的最新进展:病因、诊断和治疗选择的综述。
J Am Acad Dermatol. 2013 Nov;69(5):783-791. doi: 10.1016/j.jaad.2013.05.034. Epub 2013 Aug 19.

引用本文的文献

1
A Breakthrough in the Treatment of Necrobiosis Lipoidica? Update on Treatment, Etiopathogenesis, Diagnosis, and Clinical Presentation.硬斑病的治疗新突破?治疗、发病机制、诊断和临床表现更新。
Int J Mol Sci. 2024 Mar 20;25(6):3482. doi: 10.3390/ijms25063482.
2
Cutaneous Manifestations Associated with Diabetes Mellitus-A Retrospective Study.糖尿病相关皮肤表现——一项回顾性研究
Diseases. 2023 Aug 18;11(3):106. doi: 10.3390/diseases11030106.
3
Cutaneous Manifestation of Diabetes Mellitus in an Unsheltered Male Leading to Emergent Hospitalization.

本文引用的文献

1
Images in clinical medicine. Necrobiosis lipoidica diabeticorum.
N Engl J Med. 2012 Jun 28;366(26):2502. doi: 10.1056/NEJMicm1109700.
2
Necrobiosis lipoidica diabeticorum.糖尿病性类脂质渐进性坏死
Case Rep Pediatr. 2012;2012:152602. doi: 10.1155/2012/152602. Epub 2012 Apr 22.
3
Necrobiosis lipoidica: early diagnosis and treatment with tacrolimus.类脂质渐进性坏死:他克莫司早期诊断与治疗
Case Rep Dermatol. 2011 Apr 18;3(1):89-93. doi: 10.1159/000327936.
一名无家可归男性糖尿病的皮肤表现导致紧急住院
Cureus. 2022 Feb 21;14(2):e22432. doi: 10.7759/cureus.22432. eCollection 2022 Feb.
4
ISPAD Clinical Practice Consensus Guidelines 2018: Other complications and associated conditions in children and adolescents with type 1 diabetes.《2018年国际儿童青少年糖尿病学会临床实践共识指南:1型糖尿病儿童及青少年的其他并发症和相关病症》
Pediatr Diabetes. 2018 Oct;19 Suppl 27(Suppl 27):275-286. doi: 10.1111/pedi.12740.
5
Atypical Localization of Necrobiosis Lipoidica: Involvement of the Face and Scalp.类脂质渐进性坏死的非典型定位:累及面部和头皮。
Skin Appendage Disord. 2017 May;3(2):92-94. doi: 10.1159/000462980. Epub 2017 Mar 16.
4
Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine.羟氯喹使脂膜炎性坏死性溃疡有显著改善。
Int J Dermatol. 2010 Apr;49(4):467-9. doi: 10.1111/j.1365-4632.2010.04149.x.
5
Fumaric acid esters in severe ulcerative necrobiosis lipoidica: a case report and evaluation of current therapies.重度类脂质渐进性坏死中的富马酸酯:一例病例报告及当前治疗方法评估
Acta Derm Venereol. 2010;90(1):104-6. doi: 10.2340/00015555-0757.
6
Photodynamic therapy of necrobiosis lipoidica--a multicenter study of 18 patients.类脂质渐进性坏死的光动力疗法——18例患者的多中心研究
Dermatology. 2009;218(2):136-9. doi: 10.1159/000182259. Epub 2008 Dec 6.
7
Perforating necrobiosis lipoidica in a girl with type 1 diabetes mellitus: a new case reported.1型糖尿病女童的穿通性类脂质渐进性坏死:1例新病例报告
Dermatol Online J. 2008 Jul 15;14(7):11.
8
Necrobiosis lipoidica.
Semin Cutan Med Surg. 2007 Jun;26(2):87-9. doi: 10.1016/j.sder.2007.02.004.
9
The prevalence of cutaneous manifestations in young patients with type 1 diabetes.1型糖尿病年轻患者皮肤表现的患病率。
Diabetes Care. 2007 Aug;30(8):1964-7. doi: 10.2337/dc07-0267. Epub 2007 May 22.
10
Diabetes mellitus.糖尿病
Clin Dermatol. 2006 Jul-Aug;24(4):237-46. doi: 10.1016/j.clindermatol.2006.04.009.